<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00571883</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000577728</org_study_id>
    <secondary_id>FSRF-SEND-001</secondary_id>
    <secondary_id>EU-20794</secondary_id>
    <nct_id>NCT00571883</nct_id>
  </id_info>
  <brief_title>Neck Surgery in Treating Patients With Early-Stage Oral Cancer</brief_title>
  <official_title>SEND Trial The Role of Selective Neck Dissection Used Electively in Patients With Early Oral Squamous Cell Carcinoma (1-3cm Primary Size) and No Clinical Evidence of Lymph Node Metastases in the Neck</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Facial Surgery Research Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Surgery may be an effective treatment for oral cancer. It is not yet known whether&#xD;
      surgery to remove the tumor and lymph nodes in the neck is more effective than surgery to&#xD;
      remove the tumor alone in treating patients with early-stage oral cancer.&#xD;
&#xD;
      PURPOSE: This randomized clinical trial is comparing two types of neck surgery to see how&#xD;
      well they work in treating patients with early stage oral cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  To determine whether the use of a selective neck dissection (SEND) used electively on&#xD;
           all patients presenting with stage I-II oral cavity squamous cell carcinoma (SCC)&#xD;
           improves survival, disease-free survival, and loco-regional disease control rates.&#xD;
&#xD;
        -  To determine how SEND and complex reconstruction affect quality of life and mental&#xD;
           health.&#xD;
&#xD;
        -  To determine whether the use of SEND on all patients presenting with stage I-II oral&#xD;
           cavity SCC represents a cost-effective use of resources.&#xD;
&#xD;
      OUTLINE: This is a multicenter study. Patients are stratified by age (&lt; 40 vs 40-64 vs â‰¥ 65&#xD;
      years of age), tumor stage (T1 vs T2), and surgeon.&#xD;
&#xD;
        -  Arm I: Patients undergo resection of the primary tumor with neck dissection.&#xD;
&#xD;
        -  Arm II: Patients undergo resection of the primary tumor alone. Patients complete the&#xD;
           EORTC QLQ-C30, EORTC QLQ - H&amp;N35, and the Hospital Anxiety and Depression Scale (HADS)&#xD;
           before surgery and at 6, 12, and 24 months after surgery. Patients also complete the&#xD;
           EQ-5D questionnaire at baseline, 6 months, 12 months, and 24 months. Additionally, a&#xD;
           self-completion Health Service Use questionnaire is completed every 2 months, during the&#xD;
           first 24 months after treatment, to enable costs to the NHS to be monitored.&#xD;
&#xD;
      After surgery, patients are followed periodically for up to 5 years.&#xD;
&#xD;
      Peer Reviewed and Funded or Endorsed by Cancer Research UK.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease-free survival</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Local and regional recurrence</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Completeness of resection at the primary site</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality-of-life as measured by the EORTC QLQ-30 &amp; H&amp;N module</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Psychological well-being as measured by the Hospital Anxiety and Depression Scale (HADS) at 6, 12, and 24 months</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs to NHS, patients, and carers/families</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incremental cost per life-year saved and/or per quality-adjusted life year (QALY)</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">652</enrollment>
  <condition>Head and Neck Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>psychosocial assessment and care</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>regional lymph node dissection</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>therapeutic conventional surgery</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Patients with oral squamous cell carcinoma measuring 1 to 3 cm at the primary site&#xD;
&#xD;
          -  No clinical or preoperative imaging evidence of nodal involvement in the neck (N0)&#xD;
&#xD;
          -  Surgery is the primary mode of treatment&#xD;
&#xD;
               -  Dose not need reconstruction that necessitates opening the neck, as assessed by&#xD;
                  the surgeon&#xD;
&#xD;
          -  No cancer of the lip&#xD;
&#xD;
          -  No prior head and neck tumor&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
          -  No technical, medical, or anaesthetic difficulties that preclude patients being&#xD;
             entered into one of the trial arms&#xD;
&#xD;
          -  Not considered to be medically, socially, or psychiatrically unfit for surgery as&#xD;
             first-line treatment by the multidisciplinary team&#xD;
&#xD;
          -  No other synchronous tumor&#xD;
&#xD;
          -  No preference for non-surgical treatment&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
          -  See Disease Characteristics&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Iain Hutchison</last_name>
    <role>Study Chair</role>
    <affiliation>The Facial Surgery Research Foundation</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust</name>
      <address>
        <city>Birmingham</city>
        <state>England</state>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cumberland Infirmary</name>
      <address>
        <city>Carlisle</city>
        <state>England</state>
        <zip>CA2 7HY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Alexandra Hospital</name>
      <address>
        <city>Cosham</city>
        <state>England</state>
        <zip>PO6 3LY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Derbyshire Royal Infirmary</name>
      <address>
        <city>Derby</city>
        <state>England</state>
        <zip>DE1 2QY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Luke's Cancer Centre at Royal Surrey County Hospital</name>
      <address>
        <city>Guildford</city>
        <state>England</state>
        <zip>GU2 7XX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <state>England</state>
        <zip>LE1 5WW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lincoln County Hospital</name>
      <address>
        <city>Lincoln</city>
        <state>England</state>
        <zip>LN2 5QY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aintree University Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>England</state>
        <zip>L9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Facial Surgery Research Foundation</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Bartholomew's Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>EC1A 7BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. George's Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>SW17 0QT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College of London Hospitals</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>WIT 3AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Luton and Dunstable Hospital</name>
      <address>
        <city>Luton-Bedfordshire</city>
        <state>England</state>
        <zip>LU4 0DZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wythenshawe Hospital</name>
      <address>
        <city>Manchester</city>
        <state>England</state>
        <zip>M23 9LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle-Upon-Tyne</city>
        <state>England</state>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northampton General Hospital</name>
      <address>
        <city>Northampton</city>
        <state>England</state>
        <zip>NN1 5BD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen's Medical Centre</name>
      <address>
        <city>Nottingham</city>
        <state>England</state>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pennine Acute Hospitals</name>
      <address>
        <city>Oldham</city>
        <state>England</state>
        <zip>OL1 2PN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen's Hospital</name>
      <address>
        <city>Romford</city>
        <state>England</state>
        <zip>RM7 0AG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunderland Royal Hospital</name>
      <address>
        <city>Sunderland</city>
        <state>England</state>
        <zip>SR4 7TP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torbay Hospital</name>
      <address>
        <city>Torquay</city>
        <state>England</state>
        <zip>TQ2 7AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <state>England</state>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Falkirk and District Royal Infirmary</name>
      <address>
        <city>Falkirk</city>
        <state>Scotland</state>
        <zip>FK1 5QE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern General Hospital</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G51 4TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Crosshouse Hospital</name>
      <address>
        <city>Kilmarnock</city>
        <state>Scotland</state>
        <zip>KA2 OBE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Wales</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF14 4XW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnet General Hospital</name>
      <address>
        <city>Barnet, Hertfordshire</city>
        <zip>EN5 3DJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>December 11, 2007</study_first_submitted>
  <study_first_submitted_qc>December 11, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 12, 2007</study_first_posted>
  <last_update_submitted>December 11, 2015</last_update_submitted>
  <last_update_submitted_qc>December 11, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 14, 2015</last_update_posted>
  <keyword>stage I squamous cell carcinoma of the lip and oral cavity</keyword>
  <keyword>stage II squamous cell carcinoma of the lip and oral cavity</keyword>
  <keyword>tongue cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

